Global Anti-inflammatory Therapeutics Market By Type (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Corticosteroids, and Biologics), By Application (Arthritis, Psoriasis, Respiratory Disease, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Inflammatory Disease), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 135859
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Anti-inflammatory Therapeutics Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global anti-inflammatory therapeutics market is segmented on the basis of Type, Application, and geography.
The global Anti-inflammatory Therapeutics market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.
Anti-inflammatory Therapeutics Market Scope:
By type, the market is segmented into Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Immune Selective Anti-inflammatory Derivatives (ImSAIDs), Corticosteroids, and Biologics. By Application, the market is divided into Arthritis, Psoriasis, Respiratory Disease, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Inflammatory Disease.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca PLC, Amgen Inc, Novartis AG, F. Hoffmann-La Roche AG, and Eli Lily and Company.Key Market Segments
Type
Nonsteroidal Anti-inflammatory Diseases (NSAIDs)
Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
Corticosteroids
Biologics
Application
Arthritis
Psoriasis
Respiratory Disease
Multiple Sclerosis
Inflammatory Bowel Disease
Other Inflammatory Disease
Key Market Players included in the report:
AbbVie Inc.
Pfizer Inc.
Merck & Co., Inc.
Johnson & Johnson
GlaxoSmithKline plc
AstraZeneca PLC
Amgen Inc
Novartis AG
F. Hoffmann-La Roche AG
Eli Lily and Company
Reasons to Get this Report:
In an insight, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Anti-inflammatory Therapeutics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Anti-inflammatory Therapeutics Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Anti-inflammatory Therapeutics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Anti-inflammatory Therapeutics Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Anti-inflammatory Therapeutics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Anti-inflammatory Therapeutics Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Anti-inflammatory Therapeutics sub-markets, depending on key regions (various vital states).
To analyze Anti-inflammatory Therapeutics Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Anti-inflammatory Therapeutics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
Primary worldwide Anti-inflammatory Therapeutics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Anti-inflammatory Therapeutics Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Anti-inflammatory Therapeutics Market Overview3.1. Anti-inflammatory Therapeutics Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Anti-inflammatory Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Anti-inflammatory Therapeutics Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Nonsteroidal Anti-inflammatory Diseases (NSAIDs)4.4. Immune Selective Anti-inflammatory Derivatives (ImSAIDs)
4.5. Corticosteroids
4.6. Biologics5. Global Anti-inflammatory Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Anti-inflammatory Therapeutics Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Arthritis5.4. Psoriasis
5.5. Respiratory Disease
5.6. Multiple Sclerosis
5.7. Inflammatory Bowel Disease
5.8. Other Inflammatory Disease6. Global Anti-inflammatory Therapeutics Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Anti-inflammatory Therapeutics Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Anti-inflammatory Therapeutics Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Anti-inflammatory Therapeutics Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Anti-inflammatory Therapeutics Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Anti-inflammatory Therapeutics Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Anti-inflammatory Therapeutics Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. AbbVie Inc.7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Pfizer Inc.7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Merck & Co., Inc.7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. Johnson & Johnson7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. GlaxoSmithKline plc7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. AstraZeneca PLC7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. Amgen Inc7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Novartis AG7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. F. Hoffmann-La Roche AG7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments 7.12. Eli Lily and Company7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample